Bio-Techne (TECH) Gains from Investment Securities (2016 - 2023)
Bio-Techne's (TECH) quarterly Gains from Investment Securities came in at -$283000.0 in Q3 2023, up 40.04% quarter-over-quarter from -$472000.0 in Q2 2023.
Bio-Techne (TECH) Gains from Investment Securities (2016 - 2023) Analysis & Trends
Bio-Techne's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at -$283000.0 for Q3 2023.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$283000.0 in Q3 2023; TTM through Jun 2024 was -$283000.0, a 40.04% increase from a year earlier, with the FY2024 full-year figure at -$283000.0, up 40.04% from the prior year.
- Gains from Investment Securities improved to -$283000.0 in Q3 2023 per TECH's latest filing, from -$472000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $68.0 million in Q2 2021 and bottomed at -$111.1 million in Q1 2020.
- The 5-year median for Gains from Investment Securities is -$655500.0 (2022), against an average of -$4.8 million.
- Across the five-year window, Gains from Investment Securities jumped 372.34% in 2019 and slumped 1086.44% in 2020, its largest moves.
- Year by year, Gains from Investment Securities stood at -$10.5 million in 2019, then soared by 57.27% to -$4.5 million in 2020, then grew by 26.76% to -$3.3 million in 2021, then soared by 74.58% to -$839000.0 in 2022, then soared by 66.27% to -$283000.0 in 2023.
- Per Business Quant, the three latest TECH Gains from Investment Securities figures stand at -$283000.0 (Q3 2023), -$472000.0 (Q2 2023), and $839000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -283,000.00 |
| Sep 30, 2023 | -283,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Mar 31, 2023 | 839,000.00 |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | -839,000.00 |
| Dec 31, 2022 | -839,000.00 |
| Sep 30, 2021 | -3.30 Mn |
| Sep 30, 2021 | -3.30 Mn |
| Jun 30, 2021 | 68.03 Mn |
| Jun 30, 2021 | 68.03 Mn |
| Dec 31, 2020 | -4.51 Mn |
| Dec 31, 2020 | -4.51 Mn |
| Sep 30, 2020 | 4.35 Mn |
| Sep 30, 2020 | 4.35 Mn |
| Jun 30, 2020 | -26.26 Mn |
| Jun 30, 2020 | -26.26 Mn |
| Mar 31, 2020 | -111.12 Mn |
| Mar 31, 2020 | -111.12 Mn |